ELOVL4 antibody (ELOVL Fatty Acid Elongase 4)

Details for Product anti-ELOVL4 Antibody No. ABIN550372
Antigen
Reactivity
Human
74
26
16
15
9
3
Host
Rabbit
73
1
Clonality
Polyclonal
Conjugate
This ELOVL4 antibody is un-conjugated
7
6
3
2
2
2
1
1
1
1
1
1
Application
Western Blotting (WB)
64
49
11
6
3
2
1
1
1
Options
Purpose Rabbit polyclonal antibody raised against synthetic peptide of ELOVL4.
Immunogen A synthetic peptide corresponding to human ELOVL4.
Antigen
Alternative Name ELOVL4 (ELOVL4 Antibody Abstract)
Application Notes Western Blot (1-5 μg/mL)
The optimal working dilution should be determined by the end user.
Restrictions For Research Use only
Buffer In PBS (0.08 % sodium azide)
Storage -20 °C
Storage Comment Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Product cited in: Vasireddy, Uchida, Salem, Kim, Mandal, Reddy, Bodepudi, Alderson, Brown, Hama, Dlugosz, Elias, Holleran, Ayyagari: "Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death." in: Human molecular genetics, Vol. 16, Issue 5, pp. 471-82, 2007 (PubMed).

DeAngelis, Ji, Kim, Adams, Capone, Ott, Miller, Dryja: "Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration." in: Archives of ophthalmology, Vol. 125, Issue 1, pp. 49-54, 2007 (PubMed).

Kobayashi, Zadravec, Jacobsson: "ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells." in: FEBS letters, Vol. 581, Issue 17, pp. 3157-63, 2007 (PubMed).